Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

Abstract Objectives To address whether the use of methotrexate (MTX) and biological disease-modifying anti-rheumatic drugs (bDMARDs) impacts bone structure and biomechanical properties in patients with psoriatic arthritis (PsA). Methods This is a cross-sectional study in PsA patients receiving no DM...

Full description

Bibliographic Details
Main Authors: David Simon, Arnd Kleyer, Sara Bayat, Koray Tascilar, Eleni Kampylafka, Timo Meinderink, Louis Schuster, Ramona Petrov, Anna-Maria Liphardt, Juergen Rech, Georg Schett, Axel J. Hueber
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Arthritis Research & Therapy
Subjects:
Psoriatic arthritis
Bone
Disease-modifying anti-rheumatic drugs
Biological agents
Methotrexate
Computed tomography
Online Access:http://link.springer.com/article/10.1186/s13075-019-1938-3

Internet

http://link.springer.com/article/10.1186/s13075-019-1938-3

Similar Items